Complete Genomics, BioNanomatrix to Use $8.8M NIST Grant to Develop '$100 Genome' Platform | GenomeWeb
NEW YORK (GenomeWeb News) - BioNanomatrix and Complete Genomics said yesterday that they have formed a joint venture that will share an $8.8 million grant from the US National Institute of Standards and Technology to develop technology that will be able to sequence a human genome in eight hours for less than $100.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.